Literature DB >> 14985564

Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia.

D Israël-Biet1, H Esvant, A M Laval, J Cadranel.   

Abstract

BACKGROUND: Pneumocystis jerovici pneumonia (PJP) remains a frequent opportunistic infection in HIV infected patients which markedly upregulates HIV replication by mechanisms so far poorly elucidated. PJP triggers the production of proinflammatory mediators with activating effects on HIV. However, anti-inflammatory factors with inhibiting effects on HIV are normally produced in parallel. We postulated that an imbalance of mediators normally controlling HIV replication could underlie its marked increase during PJP.
METHODS: The production of tumour necrosis factor alpha (TNFalpha), interleukins IL-6 and IL-10, and beta-chemokine by bronchoalveolar lavage (BAL) cells recovered from HIV infected patients with and without PJP was compared. The pulmonary viral load was determined and correlations with cytokine and chemokine production were examined.
RESULTS: TNFalpha and IL-6 release was similar in patients with and without PJP but IL-10 and beta-chemokine release was markedly lower in the PJP group (IL-10: p<10(-2), RANTES, MIP-1alpha and MIP-1beta: p<0.001). The pulmonary viral load was markedly higher in patients with PJP (p<0.001) and correlated negatively with levels of MIP-1alpha, RANTES and IL-10 in BAL fluid cells (p<0.05).
CONCLUSION: Pulmonary IL-10 and beta-chemokine production is markedly defective in HIV infected patients with PJP, while pulmonary TNFalpha and IL-6 levels are normal. The resulting excess of these latter factors, which are known to upregulate HIV replication, might contribute to the increase in pulmonary viral load and to the more rapid HIV disease progression observed in patients with PJP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985564      PMCID: PMC1746968          DOI: 10.1136/thx.2003.013763

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  47 in total

1.  Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

Authors:  H D Shin; C Winkler; J C Stephens; J Bream; H Young; J J Goedert; T R O'Brien; D Vlahov; S Buchbinder; J Giorgi; C Rinaldo; S Donfield; A Willoughby; S J O'Brien; M W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines.

Authors:  T A Hamilton; Y Ohmori; J M Tebo; R Kishore
Journal:  Pathobiology       Date:  1999       Impact factor: 4.342

3.  The susceptibility of macrophages to human immunodeficiency virus type 1 X4 isolates depends on their activation state.

Authors:  Y Bakri; S Amzazi; A Mannioui; A Benjouad
Journal:  Biomed Pharmacother       Date:  2001-02       Impact factor: 6.529

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients.

Authors:  Z Toossi; H Mayanja-Kizza; C S Hirsch; K L Edmonds; T Spahlinger; D L Hom; H Aung; P Mugyenyi; J J Ellner; C W Whalen
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

6.  Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.

Authors:  H Koziel; S Kim; C Reardon; X Li; R Garland; P Pinkston; H Kornfeld
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.

Authors:  E Vicenzi; M Alfano; S Ghezzi; A Gatti; F Veglia; A Lazzarin; S Sozzani; A Mantovani; G Poli
Journal:  J Leukoc Biol       Date:  2000-09       Impact factor: 4.962

Review 8.  Permissive factors for HIV-1 infection of macrophages.

Authors:  S M Wahl; T Greenwell-Wild; H Hale-Donze; N Moutsopoulos; J M Orenstein
Journal:  J Leukoc Biol       Date:  2000-09       Impact factor: 4.962

9.  Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses.

Authors:  R Vassallo; J E Standing; A H Limper
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

10.  Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung.

Authors:  K Nakata; W N Rom; Y Honda; R Condos; S Kanegasaki; Y Cao; M Weiden
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

View more
  4 in total

1.  Lung cancer in HIV infected patients.

Authors:  Jacques Cadranel; Charles Mayaud
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

2.  Effect of bacterial pneumonia on lung simian immunodeficiency virus (SIV) replication in alcohol consuming SIV-infected rhesus macaques.

Authors:  Steve Nelson; Kyle I Happel; Ping Zhang; Leann Myers; Jason P Dufour; Gregory J Bagby
Journal:  Alcohol Clin Exp Res       Date:  2013-02-15       Impact factor: 3.455

3.  Characterization of chemokine and chemokine receptor expression during Pneumocystis infection in healthy and immunodeficient mice.

Authors:  Lisa R Bishop; Michail S Lionakis; Monica Sassi; Philip M Murphy; Xiaojun Hu; Da Wei Huang; Brad Sherman; Ju Qiu; Jun Yang; Richard A Lempicki; Joseph A Kovacs
Journal:  Microbes Infect       Date:  2015-06-05       Impact factor: 2.700

Review 4.  Abnormalities in host defense associated with HIV infection.

Authors:  James M Beck
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.